Many people discover a positive cycle where losing weight makes exercise easier, which supports more weight loss
Mounjaro alone rarely causes low blood sugar
Other important safety considerations include risks of pancreatitis, gallbladder disease, acute kidney injury (particularly from dehydration), hypoglycemia (when used with insulin or insulin secretagogues), and monitoring for depression or suicidal thoughts
Medicare and Medicaid Medicare generally does not cover medications prescribed solely for weight loss, so drugs used only for obesity treatment (such as Zepbound when prescribed for weight management) are typically not covered
Nausea incidence with GLP-1 therapies varies by agent, dose, and population, but current research indicates that roughly one in five to one in two users experience some nausea, most often during the first weeks of therapy